|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to provision of an opioid antagonist to a person who is |
|
filling a prescription for an opioid medication. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 483.103, Health and Safety Code, is |
|
amended by adding Subsection (b-1) and amending Subsection (c) to |
|
read as follows: |
|
(b-1) A pharmacist may dispense an opioid antagonist |
|
without a prescription to a person to whom the pharmacist is |
|
dispensing an opioid medication under a prescription if: |
|
(1) the opioid is prescribed in conjunction with |
|
benzodiazepine medication; |
|
(2) the prescription of the dispensed medication |
|
directs the patient to take 90 morphine milligram equivalents or |
|
more daily; |
|
(3) in the pharmacist's professional opinion, the |
|
patient is at risk of accidental overdose or potential abuse or |
|
overuse; or |
|
(4) the physician who issued the prescription has |
|
communicated to the pharmacist that in the physician's professional |
|
opinion, the patient is at risk of accidental overdose or potential |
|
abuse or overuse. |
|
(c) A pharmacist who, acting in good faith and with |
|
reasonable care, dispenses or does not dispense an opioid |
|
antagonist under a valid prescription or on the pharmacist's own |
|
initiative under Subsection (b-1) is not subject to any criminal or |
|
civil liability or any professional disciplinary action for: |
|
(1) dispensing or failing to dispense the opioid |
|
antagonist; or |
|
(2) if the pharmacist chooses to dispense an opioid |
|
antagonist, any outcome resulting from the eventual administration |
|
of the opioid antagonist. |
|
SECTION 2. The change in law made by this Act applies only |
|
to a person to whom the pharmacist dispenses an opioid medication |
|
under a prescription on or after the effective date of this Act. |
|
SECTION 3. This Act takes effect September 1, 2021. |